NT-proBNP (N-terminal pro-B-type natriuretic peptide) has been shown to be a relevant marker of ventricular dysfunction and cardiac ischemia, being frequently elevated in RA patients, despite the lack of overt CVD risk factors. This evidence concerns the gene NPPB and rheumatoid arthritis.